Standard Interpretations - Table of Contents|
| Standard Number:||1910.1030(c)(1)(iv)(A); 1910.1030(c)(1)(iv)(B); 1910.1030(c)(1)(v); 1910.1030(d)(2)(i); 1910.1030|
We (Terumo) understand that the evaluation of new sharps safety devices should be conducted by frontline healthcare workers. Many healthcare facilities operate under a Group Purchasing Organization (GPO) contact, intended to organize purchasing and availability of medical supplies. The GPOs typically offer little, if any, variation with regard to needlestick safety products. In light of the OSHA requirements to use safer medical devices dependent on an evaluation performed by healthcare workers, GPOs should not restrict the selection and evaluation of such products. What is OSHA's viewpoint on this?Your interpretation is correct. Devices must be selected based on employee feedback (29 CFR 1910.1030(c)(1)(v)). They must be evaluated for appropriateness for each procedure and effectiveness in preventing occupational exposures to blood and other potentially infectious materials (OPIM). If the availability and variety of devices is restricted, the employer may be in violation of the requirements: (1) to review and update the exposure control plan to reflect changes in technology that eliminate or reduce exposure to blood and OPIM (29 CFR 1910.1030(c)(1)(iv)(A)); (2) to review and update the plan annually, documenting the consideration and implementation of appropriate commercially available and effective safer medical devices designed to eliminate or minimize occupational exposure (29 CFR 1910.1030(c)(i)(iv)(B); and (3) to use engineering controls to eliminate or minimize employee exposure (29 CFR 1910.1030(d)(2)(i)).
|Standard Interpretations - Table of Contents|